JOINDER TO STOCKHOLDERS’ AGREEMENTJoinder Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Stockholders’ Agreement dated as of May 10, 2017 (the “Stockholders’ Agreement”) by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), Thomas H. Lee Equity Fund VI, L.P. and the other signatories that are party thereto as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning ascribed to such terms in the Stockholders’ Agreement.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • March 5th, 2021 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
SILVER POINT CAPITAL FUND, L.P. SILVER POINT CAPITAL OFFSHORE FUND, LTD. SPCP GROUP, LLC c/o Silver Point Capital Fund, L.P.Lee Thomas H Advisors LLC • March 9th, 2011 • Services-business services, nec
Reference is made to the Registration Rights Agreement, dated as of March 25, 2008 (the “Agreement”). Capitalized terms used and not otherwise defined herein are used herein as defined in the Agreement. The undersigned party set forth under the heading “Silver Point” (the “Transferee”) hereby: (i) acknowledges receipt of a copy of the Agreement; (ii) notifies the Company that, on December 2, 2009, Transferee acquired from Silver Point Capital Fund, L.P. and Silver Point Capital Offshore Fund, LTD. (together, the “Transferor”) (pursuant to a private transfer that was exempt from the registration requirements under the Securities Act) the number of shares of Series B Participating Convertible Preferred Stock of the Company (the “Transferred Securities”) set forth opposite the Transferee’s name on Schedule 1 attached hereto and an assignment of Transferor’s rights under the Agreement with respect to the Transferred Securities, and the Transferee has assumed from Transferor the liability o
Joint Filing AgreementJoint Filing Agreement • March 11th, 2009 • Lee Thomas H Advisors LLC • Services-amusement & recreation services
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • May 11th, 2021 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
Syneos Health, Inc. Lock-Up Agreement August 6, 2018Thomas H. Lee Advisors, LLC • August 13th, 2018 • Services-commercial physical & biological research
RECAPITALIZATION AGREEMENTRecapitalization Agreement • March 9th, 2011 • Lee Thomas H Advisors LLC • Services-business services, nec • Delaware
This RECAPITALIZATION AGREEMENT, dated as of March 7, 2011 (this “Agreement”), is by and among MoneyGram International, Inc., a Delaware corporation (the “Company”), the investors listed under the heading “THL Investors” on Exhibit A hereto (the “THL Investors”) and the investors listed under the heading “GS Investors” on Exhibit A hereto (the “GS Investors” and, together with the THL Investors, the “Investors”).
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • June 9th, 2021 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
AMENDMENT NO. 1 TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENTShareholders Agreement • May 23rd, 2011 • Thomas H. Lee Advisors, LLC • Services-business services, nec • New York
This Amendment No. 1 to Amended and Restated Shareholders Agreement (this “Amendment”), dated as of May 18, 2011, by and among the investors listed under the heading “THL Investors” on the signature pages hereto (the “THL Investors”) and the investors listed under the heading “GS Investors” on the signature pages hereto (the “GS Investors” and, together with the THL Investors, the “Investors”). The Investors are sometimes referred to herein collectively as the “Parties.”
Joint Filing AgreementJoint Filing Agreement • August 10th, 2017 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to Class A common stock, par value $0.01 per share, of INC Research Holdings Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 10th day of August , 2017.
JOINDER AGREEMENT TO SHAREHOLDERS AGREEMENTJoinder Agreement to Shareholders Agreement • March 9th, 2011 • Lee Thomas H Advisors LLC • Services-business services, nec • New York
JOINDER AGREEMENT dated as of December 2, 2009, by and among Thomas H. Lee Equity Fund VI, L.P., Thomas H. Lee Parallel Fund VI, L.P., Thomas H. Lee Parallel (DT) Fund VI, L.P., Thomas H. Lee Equity Fund VI Investors (MoneyGram), LLC, THL Operating Partners, L.P, THL Coinvestment Partners, L.P., Great-West Investors, L.P., Putnum Investments Employees’ Securities Company III, LLC (collectively, the “THL Parties”), GS Capital Partners VI Fund, L.P., GS Capital Partners VI Offshore Fund, L.P., GS Capital Partners VI GmbH & Co. KG, GS Capital Partners VI Parallel, L.P., GSMP V Onshore US, Ltd., GSMP V Offshore US, Ltd., GSMP V Institutional US, Ltd., and The Goldman Sachs Group, Inc. (collectively, the “GS Parties”), Silver Point Capital Offshore Fund, Ltd. and Silver Point Capital Fund, L.P. (collectively, the “SP Parties”), and SPCP Group, LLC (the “New Unitholder”) (the “Agreement”). Capitalized terms used but not defined herein have the meaning ascribed to them in the Shareholders Agr
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GThomas H. Lee Advisors, LLC • April 28th, 2014 • Savings institution, federally chartered
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GThomas H. Lee Advisors, LLC • February 14th, 2014 • Retail-eating places
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
JOINDER TO STOCKHOLDERS’ AGREEMENTJoinder Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Stockholders’ Agreement dated as of May 10, 2017 (the “Stockholders’ Agreement”) by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), Thomas H. Lee Equity Fund VI, L.P. and the other signatories that are party thereto as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning ascribed to such terms in the Stockholders’ Agreement.
PREEMPTIVE RIGHTS WAIVERPreemptive Rights Waiver • July 2nd, 2019 • Thomas H. Lee Advisors, LLC • Services-business services, nec • Delaware
THIS PREEMPTIVE RIGHTS WAIVER (this “Waiver”) is made as of June 17, 2019, by the holders of common stock of MoneyGram International, Inc., a Delaware corporation (the “Company”), listed on the signature pages hereto (the “Holders”), for the benefit of the Company. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in that certain Amended and Restated Purchase Agreement, dated as of March 17, 2008 (this “Purchase Agreement”), among the Company and the parties set forth on Schedule A thereto (collectively, the “Investors”).
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GThomas H. Lee Advisors, LLC • February 14th, 2014 • Services-business services, nec
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • September 21st, 2020 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
AMENDMENT NO. 1 TO RECAPITALIZATION AGREEMENTRecapitalization Agreement • May 9th, 2011 • Lee Thomas H Advisors LLC • Services-business services, nec • Delaware
This Amendment No. 1 to Recapitalization Agreement (this “Amendment”), dated as of May 4, 2011, by and among MoneyGram International, Inc., a Delaware corporation (the “Company”), the investors listed under the heading “THL Investors” on the signature pages hereto (the “THL Investors”) and the investors listed under the heading “GS Investors” on the signature pages hereto (the “GS Investors” and, together with the THL Investors, the “Investors”). The Company and the Investors are sometimes referred to herein collectively as the “Parties.”
